164 related articles for article (PubMed ID: 18996907)
21. A protocol for preventative mastectomy in women with an increased lifetime risk of breast cancer.
Lalloo F; Baildam A; Brain A; Hopwood P; Evans DG; Howell A
Eur J Surg Oncol; 2000 Nov; 26(7):711-3. PubMed ID: 11078619
[TBL] [Abstract][Full Text] [Related]
22. Psychological distress and quality of life associated with genetic testing for breast cancer risk.
Smith AW; Dougall AL; Posluszny DM; Somers TJ; Rubinstein WS; Baum A
Psychooncology; 2008 Aug; 17(8):767-73. PubMed ID: 17992698
[TBL] [Abstract][Full Text] [Related]
23. Risk factors associated with the occurrence of breast cancer after bilateral salpingo-oophorectomy in high-risk women.
Ramon Y Cajal T; Torres A; Alonso C; Fisas D; Ojeda B; Boguña I; Prat J; Baiget M; Barnadas A
Cancer Epidemiol; 2011 Feb; 35(1):78-82. PubMed ID: 20638925
[TBL] [Abstract][Full Text] [Related]
24. Oral contraceptive use and BRCA penetrance: a case-only study.
Pasanisi P; Hédelin G; Berrino J; Chang-Claude J; Hermann S; Steel M; Haites N; Hart J; Peled R; Gafà L; Leggio L; Traina A; Amodio R; Primic-Zakelj M; Zadnik V; Veidebaum T; Tekkel M; Berrino F
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2107-13. PubMed ID: 19549808
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers: a cost-effectiveness analysis.
Norum J; Hagen AI; Maehle L; Apold J; Burn J; Møller P
Eur J Cancer; 2008 May; 44(7):963-71. PubMed ID: 18362067
[TBL] [Abstract][Full Text] [Related]
26. [Molecular genetics and clinics of hereditary breast cancer].
Schmutzler RK
Verh Dtsch Ges Pathol; 2005; 89():25-34. PubMed ID: 18035669
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a surveillance programme for women with a family history of breast cancer.
Reis MM; Tavakoli M; Dewar J; Goudie D; Cook A; McLeish L; Young D; Kenyon J; Steel M
J Med Genet; 2009 May; 46(5):319-23. PubMed ID: 19279022
[TBL] [Abstract][Full Text] [Related]
28. Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret.
van Dijk S; van Roosmalen MS; Otten W; Stalmeier PF
J Clin Oncol; 2008 May; 26(14):2358-63. PubMed ID: 18467728
[TBL] [Abstract][Full Text] [Related]
29. Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study.
Brandberg Y; Sandelin K; Erikson S; Jurell G; Liljegren A; Lindblom A; Lindén A; von Wachenfeldt A; Wickman M; Arver B
J Clin Oncol; 2008 Aug; 26(24):3943-9. PubMed ID: 18711183
[TBL] [Abstract][Full Text] [Related]
30. The advanced practice nursing role in a high-risk breast cancer clinic.
Vogel WH
Oncol Nurs Forum; 2003; 30(1):115-22. PubMed ID: 12515989
[TBL] [Abstract][Full Text] [Related]
31. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.
Vadaparampil ST; Quinn GP; Miree CA; Brzosowicz J; Carter B; Laronga C
Ann Surg Oncol; 2009 Jul; 16(7):1973-81. PubMed ID: 19408048
[TBL] [Abstract][Full Text] [Related]
32. [Women with hereditary risk of breast cancer: consensus of surgical representatives of study groups for hereditary tumors regarding intensive monitoring, diagnosis and preventive resection].
van Geel AN; Rutgers EJ; Vos-Deckers GC; de Vries J; Wobbes T
Ned Tijdschr Geneeskd; 1997 May; 141(18):874-7. PubMed ID: 9273451
[TBL] [Abstract][Full Text] [Related]
33. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
[TBL] [Abstract][Full Text] [Related]
34. Personal health behaviors in women who have undergone risk-reducing mastectomy.
Specht MC; Borgen PI; Fey J; Zhang Z; Sclafani L
Am J Surg; 2004 Oct; 188(4):448-9. PubMed ID: 15474447
[TBL] [Abstract][Full Text] [Related]
35. A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer.
Michelsen TM; Dørum A; Dahl AA
Gynecol Oncol; 2009 Apr; 113(1):128-33. PubMed ID: 19178933
[TBL] [Abstract][Full Text] [Related]
36. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.
Granader EJ; Dwamena B; Carlos RC
Acad Radiol; 2008 Dec; 15(12):1590-5. PubMed ID: 19000876
[TBL] [Abstract][Full Text] [Related]
37. Quality of life after bilateral prophylactic mastectomy.
Geiger AM; Nekhlyudov L; Herrinton LJ; Rolnick SJ; Greene SM; West CN; Harris EL; Elmore JG; Altschuler A; Liu IL; Fletcher SW; Emmons KM
Ann Surg Oncol; 2007 Feb; 14(2):686-94. PubMed ID: 17103066
[TBL] [Abstract][Full Text] [Related]
38. Establishing a family risk assessment clinic for breast cancer.
Mulsow J; Lee J; Dempsey C; Rothwell J; Geraghty JG
Breast J; 2009; 15 Suppl 1():S33-8. PubMed ID: 19775328
[TBL] [Abstract][Full Text] [Related]
39. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women.
Taneja C; Edelsberg J; Weycker D; Guo A; Oster G; Weinreb J
J Am Coll Radiol; 2009 Mar; 6(3):171-9. PubMed ID: 19248993
[TBL] [Abstract][Full Text] [Related]
40. The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy.
Bresser PJ; Seynaeve C; Van Gool AR; Niermeijer MF; Duivenvoorden HJ; van Dooren S; van Geel AN; Menke-Pluijmers MB; Klijn JG; Tibben A
Eur J Cancer; 2007 Jan; 43(1):95-103. PubMed ID: 17095208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
